248 related articles for article (PubMed ID: 27816763)
21. Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha.
Li G; Brocker CN; Yan T; Xie C; Krausz KW; Xiang R; Gonzalez FJ
Mol Metab; 2018 Jan; 7():80-89. PubMed ID: 29146411
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
23. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study.
Martin PG; Guillou H; Lasserre F; Déjean S; Lan A; Pascussi JM; Sancristobal M; Legrand P; Besse P; Pineau T
Hepatology; 2007 Mar; 45(3):767-77. PubMed ID: 17326203
[TBL] [Abstract][Full Text] [Related]
24. Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice.
Zhang C; Wang G; Zheng Z; Maddipati KR; Zhang X; Dyson G; Williams P; Duncan SA; Kaufman RJ; Zhang K
Hepatology; 2012 Apr; 55(4):1070-82. PubMed ID: 22095841
[TBL] [Abstract][Full Text] [Related]
25. Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis.
Yan T; Luo Y; Yan N; Hamada K; Zhao N; Xia Y; Wang P; Zhao C; Qi D; Yang S; Sun L; Cai J; Wang Q; Jiang C; Gavrilova O; Krausz KW; Patel DP; Yu X; Wu X; Hao H; Liu W; Qu A; Gonzalez FJ
Hepatology; 2023 Jan; 77(1):239-255. PubMed ID: 35460276
[TBL] [Abstract][Full Text] [Related]
26. PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.
Abdelmegeed MA; Yoo SH; Henderson LE; Gonzalez FJ; Woodcroft KJ; Song BJ
J Nutr; 2011 Apr; 141(4):603-10. PubMed ID: 21346097
[TBL] [Abstract][Full Text] [Related]
27. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.
Stec DE; Gordon DM; Hipp JA; Hong S; Mitchell ZL; Franco NR; Robison JW; Anderson CD; Stec DF; Hinds TD
Am J Physiol Regul Integr Comp Physiol; 2019 Nov; 317(5):R733-R745. PubMed ID: 31483154
[TBL] [Abstract][Full Text] [Related]
28. Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice.
Brocker CN; Patel DP; Velenosi TJ; Kim D; Yan T; Yue J; Li G; Krausz KW; Gonzalez FJ
J Lipid Res; 2018 Nov; 59(11):2140-2152. PubMed ID: 30158201
[TBL] [Abstract][Full Text] [Related]
29. N-3 fatty acids reduced trans fatty acids retention and increased docosahexaenoic acid levels in the brain.
Lavandera JV; Saín J; Fariña AC; Bernal CA; González MA
Nutr Neurosci; 2017 Sep; 20(7):424-435. PubMed ID: 27098669
[TBL] [Abstract][Full Text] [Related]
30. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
31. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
[TBL] [Abstract][Full Text] [Related]
32. Nordihydroguaiaretic Acid, a Lignan from
Chan JKW; Bittner S; Bittner A; Atwal S; Shen WJ; Inayathullah M; Rajada J; Nicolls MR; Kraemer FB; Azhar S
J Pharmacol Exp Ther; 2018 May; 365(2):281-290. PubMed ID: 29472517
[TBL] [Abstract][Full Text] [Related]
33. Lack of peroxisome proliferator-activated receptor alpha in mice enhances methionine and choline deficient diet-induced steatohepatitis.
Kashireddy PV; Rao MS
Hepatol Res; 2004 Oct; 30(2):104-110. PubMed ID: 15519275
[TBL] [Abstract][Full Text] [Related]
34. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
López-Oliva ME; Garcimartin A; Muñoz-Martínez E
Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
[TBL] [Abstract][Full Text] [Related]
35. A lard-rich high-fat diet increases hepatic peroxisome proliferator-activated receptors in endotoxemic rats.
Kai M; Miyoshi M; Fujiwara M; Nishiyama Y; Inoue T; Maeshige N; Hamada Y; Usami M
J Surg Res; 2017 May; 212():22-32. PubMed ID: 28550910
[TBL] [Abstract][Full Text] [Related]
36. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
Luo L; Fang K; Dan X; Gu M
Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
[TBL] [Abstract][Full Text] [Related]
37. Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content.
Machado RM; Stefano JT; Oliveira CP; Mello ES; Ferreira FD; Nunes VS; de Lima VM; Quintão EC; Catanozi S; Nakandakare ER; Lottenberg AM
J Nutr; 2010 Jun; 140(6):1127-32. PubMed ID: 20357081
[TBL] [Abstract][Full Text] [Related]
38. Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats.
Jeyapal S; Putcha UK; Mullapudi VS; Ghosh S; Sakamuri A; Kona SR; Vadakattu SS; Madakasira C; Ibrahim A
Eur J Nutr; 2018 Sep; 57(6):2171-2187. PubMed ID: 28676973
[TBL] [Abstract][Full Text] [Related]
39. The odd-carbon medium-chain fatty triglyceride triheptanoin does not reduce hepatic steatosis.
Comhair TM; Garcia Caraballo SC; Dejong CH; Lamers WH; Koehler SE
Clin Nutr; 2017 Feb; 36(1):229-237. PubMed ID: 26778339
[TBL] [Abstract][Full Text] [Related]
40. Roles of Peroxisome Proliferator-Activated Receptor α in Bitter Melon Seed Oil-Corrected Lipid Disorders and Conversion of α-Eleostearic Acid into Rumenic Acid in C57BL/6J Mice.
Chang YY; Su HM; Chen SH; Hsieh WT; Chyuan JH; Chao PM
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
